MedPath

ELREXFIO 40 MG/ML SOLUCION INYECTABLE

ELREXFIO 40 MG/ML SOLUCION INYECTABLE

Commercialized
Register Number

1231770001

Prescription Type

Uso Hospitalario

Authorization Date

Dec 18, 2023

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1231770001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ELRANATAMABActive
Quantity: 40 mg
Name: ELRANATAMAB

ATC CLASSIFICATION (3)

L01F
L01FX
L01FX32

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.